[Practical guidelines for blood transfusions in Germany].
During the last decades drug safety of blood- and plasma products have been raised significantly. Moreover, since 2008 the usage of blood- and plasma products was determined in a clinical practice guideline for blood- and plasma products by the Bundesärztekammer. This document underlays a current update and exists in it's actual 4. revision. Aim oft the manuscript presented is to summarize the content of these clinical practice guidelines concerning the most important points like indications for transfusion (physiological and hb-bound transfusion triggers), the right choice of red blood cell concentrate, and the most common side effects.